Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 911–920 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 911
- Medicine slug
- magnesium
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 125
- Source count
- 6
- Agreement rate
- 1
- Recorded readings
8.5 hours
- Numeric value
- 8.5
- Unit
- hours
- Source records
- 6
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 6 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f23abd-6a66-44cb-960e-d43c16a5ae5f (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of SUPREP Bowel Prep Kit in six healthy subjects, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f86bdcc8-e643-4160-89ae-01c89bee842d (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy subjects, the time at which serum sulfate reached its highest point (T max ) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4883657-d27d-4056-a567-5fb12d5e05d1 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy volunteers, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first half dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5f06de-ee98-44c0-be7e-9a998d1e5c16 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of SUPREP Bowel Prep Kit in six healthy subjects, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f269929e-c2ff-4288-9d3b-7770bcb5a498 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy subjects, the time at which serum sulfate reached its highest point (T max ) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af53cca9-d7db-4723-ad7a-bee09484dbb0 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy volunteers, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first half dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
Projected row 912
- Medicine slug
- magnesium
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 125
- Source count
- 6
- Agreement rate
- 1
- Recorded readings
17 hours
- Numeric value
- 17
- Unit
- hours
- Source records
- 6
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 6 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:50f23abd-6a66-44cb-960e-d43c16a5ae5f (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of SUPREP Bowel Prep Kit in six healthy subjects, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f86bdcc8-e643-4160-89ae-01c89bee842d (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy subjects, the time at which serum sulfate reached its highest point (T max ) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d4883657-d27d-4056-a567-5fb12d5e05d1 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy volunteers, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first half dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2f5f06de-ee98-44c0-be7e-9a998d1e5c16 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of SUPREP Bowel Prep Kit in six healthy subjects, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f269929e-c2ff-4288-9d3b-7770bcb5a498 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption and Elimination After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy subjects, the time at which serum sulfate reached its highest point (T max ) was approximately 17 hours after the first dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af53cca9-d7db-4723-ad7a-bee09484dbb0 (opens source in a new tab)
Magnesium label
Version not recorded · Effective date not recorded
After administration of Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution in six healthy volunteers, the time at which serum sulfate reached its highest point (Tmax) was approximately 17 hours after the first half dose or approximately 5 hours after the second dose, and then declined with a half-life of 8.5 hours.
Projected row 913
- Medicine slug
- mannitol
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 9
- Source count
- 6
- Agreement rate
- 0.833333
- Recorded readings
0.5 to 2.5 hours
- Numeric value
- 0.5
- Unit
- hours
- Source records
- 5
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 5 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d914965-7001-45cb-ba51-d7c5964b05bc (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The elimination half-life of mannitol is 0.5 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The elimination half-life of mannitol is 0.5 to 2.5 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ad3145e-00e7-4412-b9a5-06f00f264f30 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The elimination half-life of mannitol is 0.5 to 2.5 hours Metabolism Only a relatively small amount of the mannitol dose is metabolized after intravenous administration to healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e2444db1-9dfe-451f-a33c-9b00786464d2 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The elimination half-life of mannitol is 0.5 to 2.5 hours Metabolism Only a relatively small amount of the mannitol dose is metabolized after intravenous administration to healthy subjects.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d12cc802-b538-4065-a264-f474ff3b3043 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The elimination half-life of mannitol is 0.5 to 2.5 hours.
0.16 hour
- Numeric value
- 0.16
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:999ce711-2d5b-0d7d-e053-2995a90a2689 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The plasma half-life for this distribution phase is 0.16 hour.
Projected row 914
- Medicine slug
- mannitol
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 9
- Source count
- 6
- Agreement rate
- 1
- Recorded readings
17 L
- Numeric value
- 17
- Unit
- L
- Source records
- 6
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 6 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0d914965-7001-45cb-ba51-d7c5964b05bc (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:999ce711-2d5b-0d7d-e053-2995a90a2689 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8ad3145e-00e7-4412-b9a5-06f00f264f30 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e2444db1-9dfe-451f-a33c-9b00786464d2 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d12cc802-b538-4065-a264-f474ff3b3043 (opens source in a new tab)
Mannitol label
Version not recorded · Effective date not recorded
The volume of distribution of mannitol is approximately 17 L in adults.
Projected row 915
- Medicine slug
- maraviroc
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 10
- Source count
- 10
- Agreement rate
- 1
- Recorded readings
23%
- Numeric value
- 23
- Unit
- %
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7b9c67b-10c6-45b5-b2a8-952cd350b0b1 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100‑mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bba17ba-0bc5-430c-96d1-c568e236a0ed (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100-mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46f30ac5-c96b-429e-976d-8c5ee1c0761b (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100‑mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:211290a4-5e26-4784-aa99-8ccaf2eaaa15 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100-mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c4a1da5-a8e1-4038-970d-fb15c189c35e (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100‑mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a16417d-a3b8-483b-9dfe-d5263cc16538 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100‑mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09ec3e79-c0d3-4b8f-80d8-0a854c4ca339 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100-mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c52dddd-0457-41cd-99e0-d30d4fd00ec5 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100‑mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3a728e2-1866-462e-bfcc-5f3c9dd88794 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100-mg dose is 23% and is predicted to be 33% at 300 mg.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c5f41e8-d358-403a-b199-6b9028b52748 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The absolute bioavailability of a 100-mg dose is 23% and is predicted to be 33% at 300 mg.
Projected row 916
- Medicine slug
- maraviroc
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 10
- Source count
- 10
- Agreement rate
- 1
- Recorded readings
194 L
- Numeric value
- 194
- Unit
- L
- Source records
- 10
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 10 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7b9c67b-10c6-45b5-b2a8-952cd350b0b1 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bba17ba-0bc5-430c-96d1-c568e236a0ed (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:46f30ac5-c96b-429e-976d-8c5ee1c0761b (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:211290a4-5e26-4784-aa99-8ccaf2eaaa15 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5c4a1da5-a8e1-4038-970d-fb15c189c35e (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2a16417d-a3b8-483b-9dfe-d5263cc16538 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09ec3e79-c0d3-4b8f-80d8-0a854c4ca339 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3c52dddd-0457-41cd-99e0-d30d4fd00ec5 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d3a728e2-1866-462e-bfcc-5f3c9dd88794 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c5f41e8-d358-403a-b199-6b9028b52748 (opens source in a new tab)
Maraviroc label
Version not recorded · Effective date not recorded
The volume of distribution of maraviroc is approximately 194 L.
Projected row 917
- Medicine slug
- margetuximab-cmkb
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
19.2 days
- Numeric value
- Not parsed
- Unit
- Not recorded
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a6d50c7-06ea-479c-83cc-f197a9e428c9 (opens source in a new tab)
Margetuximab-Cmkb label
Version not recorded · Effective date not recorded
Elimination The geometric mean (%CV) terminal half-life of margetuximab-cmkb is 19.2 days (28%) and clearance is 0.22 L/day (24%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e97a5872-eabf-463b-8f4c-5b5aed9c7bf0 (opens source in a new tab)
Margetuximab-Cmkb label
Version not recorded · Effective date not recorded
Elimination The geometric mean (%CV) terminal half-life of margetuximab-cmkb is 19.2 days (28%) and clearance is 0.22 L/day (24%).
Projected row 918
- Medicine slug
- margetuximab-cmkb
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 2
- Source count
- 2
- Agreement rate
- 1
- Recorded readings
5.47 L
- Numeric value
- 5.47
- Unit
- L
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a6d50c7-06ea-479c-83cc-f197a9e428c9 (opens source in a new tab)
Margetuximab-Cmkb label
Version not recorded · Effective date not recorded
Distribution Margetuximab-cmkb geometric mean (%CV) steady-state volume of distribution is 5.47 L (22%).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e97a5872-eabf-463b-8f4c-5b5aed9c7bf0 (opens source in a new tab)
Margetuximab-Cmkb label
Version not recorded · Effective date not recorded
Distribution Margetuximab-cmkb geometric mean (%CV) steady-state volume of distribution is 5.47 L (22%).
Projected row 919
- Medicine slug
- meclizine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 122
- Source count
- 54
- Agreement rate
- 1
- Recorded readings
5-6 hours
- Numeric value
- 5
- Unit
- hours
- Source records
- 54
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 54 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c31846b2-d47d-a97b-e053-2a95a90a9bec (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:949f7347-8c3a-43ce-b975-8d187096f09f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7d31433-8f39-4fe6-b542-1b4410122db7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1079db3f-d8ad-4c25-aa91-8ac8054ee4f2 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dab43efd-bec6-472f-b13a-1c043914dcd1 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d53bf04e-5cfc-4974-9b24-2cce545d1bd0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd657ba-46dc-4106-9f6a-dfa0ecf85752 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bd (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b11c10b9-f40e-4ea7-9c5d-118517049f9d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27b6a7e0-a361-4705-9f31-719063a65f22 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a8cbc12-0725-4462-bb71-0b18cefc19e7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae4bc73-fee1-4831-b31c-8ca56fb83ad7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37457bd5-2fdd-b829-e063-6294a90a04f0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b4716c-411a-62cd-e053-2a95a90a6f4b (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2df6edde-4479-ed9d-e063-6394a90abdc1 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6b3f4d8-5fcf-2278-e053-2a95a90ab139 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53f410fd-104c-42c1-9740-6f48ffbc974f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beb3c7f2-c0f4-41d9-a903-63a6847e0997 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:947a03c5-bca0-4d97-90b9-bcd6d6588273 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e0ed1fc-53e6-a3b1-e063-6394a90af419 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51c96c7a-0a38-41a5-a6c9-7f45db65fdda (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2990e296-2d60-70c0-e063-6394a90abbe4 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:112103bc-25e2-42cf-8542-ba1d3392a2c3 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c66ee38-10bb-4559-9d2f-51e6d6f091ee (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18fe5e13-5583-45ee-ab6e-32e9af426bd8 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af5d0c9b-a997-8033-afca-3c04221f2e76 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21d4a6ee-0a66-45d7-bab9-c5eef399713d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87d4c6d8-9218-48c2-9163-615a32449f11 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beb36d86-9fb7-1f60-e053-2995a90aac13 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4727e7a9-eabb-a2a7-e063-6394a90a8754 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:666dc4d8-7b16-4c3c-84e4-645548dbee68 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:467e464b-bbaf-4053-9136-39e47a92fa05 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91b1fd1a-1da2-4aae-826f-7de0bfe62161 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a33dec1-8d59-48bd-aaef-77d162194d57 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27fe828-4fee-3ba9-e053-2995a90ae7b6 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9350fefc-9c00-182c-c3a9-044d4a40856f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52ee9258-8311-e6bd-e063-6294a90a567f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53df5b1b-64da-e805-e063-6294a90a0a55 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d31ae73-3f09-a77c-e063-6294a90ade9a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af1e45ca-1478-4eeb-8fdc-4f3d3eda4ed5 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c443873a-2e89-43b2-b145-dde3dadf7bc0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6a5df4b-5cbf-4a0c-b38a-f4509c9c17db (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:598eb392-1dfe-c08c-e063-6394a90a4c7d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b91435d1-fb95-4939-8478-84e41f44f732 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:522b55a2-313c-45e8-b1be-07746ada5b0a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff719d9c-8d80-42db-97a5-022a75773623 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:81e1762b-e012-4c6d-96e6-9a9f27a1880a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f99f13ab-33c0-4304-8dc5-3a75f3909377 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:92e8390b-5173-4aa1-906d-35d2c0eaaaf6 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf157a71-f80a-4fb7-b892-7102b65a8ec0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e79ecf77-0e0a-d7ef-e053-2a95a90a5adf (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5-6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e262d9-d9dd-43a3-bc74-35e46dd391be (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b541252-e8a7-b678-e063-6394a90a34dc (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f755f8f3-7645-433c-b502-c1f15b700299 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Elimination: Meclizine has a plasma elimination half-life of about 5 to 6 hours in humans.
Projected row 920
- Medicine slug
- meclizine
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 122
- Source count
- 54
- Agreement rate
- 1
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 54
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 54 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c31846b2-d47d-a97b-e053-2a95a90a9bec (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:949f7347-8c3a-43ce-b975-8d187096f09f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d7d31433-8f39-4fe6-b542-1b4410122db7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1079db3f-d8ad-4c25-aa91-8ac8054ee4f2 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dab43efd-bec6-472f-b13a-1c043914dcd1 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d53bf04e-5cfc-4974-9b24-2cce545d1bd0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6dd657ba-46dc-4106-9f6a-dfa0ecf85752 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9ddc39c-bc6b-42f1-8c5f-5aff2d79c4bd (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b11c10b9-f40e-4ea7-9c5d-118517049f9d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27b6a7e0-a361-4705-9f31-719063a65f22 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6a8cbc12-0725-4462-bb71-0b18cefc19e7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:eae4bc73-fee1-4831-b31c-8ca56fb83ad7 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:37457bd5-2fdd-b829-e063-6294a90a04f0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2b4716c-411a-62cd-e053-2a95a90a6f4b (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2df6edde-4479-ed9d-e063-6394a90abdc1 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6b3f4d8-5fcf-2278-e053-2a95a90ab139 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53f410fd-104c-42c1-9740-6f48ffbc974f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beb3c7f2-c0f4-41d9-a903-63a6847e0997 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:947a03c5-bca0-4d97-90b9-bcd6d6588273 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2e0ed1fc-53e6-a3b1-e063-6394a90af419 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51c96c7a-0a38-41a5-a6c9-7f45db65fdda (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2990e296-2d60-70c0-e063-6394a90abbe4 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:112103bc-25e2-42cf-8542-ba1d3392a2c3 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6c66ee38-10bb-4559-9d2f-51e6d6f091ee (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18fe5e13-5583-45ee-ab6e-32e9af426bd8 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af5d0c9b-a997-8033-afca-3c04221f2e76 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:21d4a6ee-0a66-45d7-bab9-c5eef399713d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87d4c6d8-9218-48c2-9163-615a32449f11 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:beb36d86-9fb7-1f60-e053-2995a90aac13 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4727e7a9-eabb-a2a7-e063-6394a90a8754 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:666dc4d8-7b16-4c3c-84e4-645548dbee68 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:467e464b-bbaf-4053-9136-39e47a92fa05 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:91b1fd1a-1da2-4aae-826f-7de0bfe62161 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median Tmax value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a33dec1-8d59-48bd-aaef-77d162194d57 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d27fe828-4fee-3ba9-e053-2995a90ae7b6 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median Tmax value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9350fefc-9c00-182c-c3a9-044d4a40856f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:52ee9258-8311-e6bd-e063-6294a90a567f (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:53df5b1b-64da-e805-e063-6294a90a0a55 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d31ae73-3f09-a77c-e063-6294a90ade9a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:af1e45ca-1478-4eeb-8fdc-4f3d3eda4ed5 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c443873a-2e89-43b2-b145-dde3dadf7bc0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e6a5df4b-5cbf-4a0c-b38a-f4509c9c17db (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:598eb392-1dfe-c08c-e063-6394a90a4c7d (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b91435d1-fb95-4939-8478-84e41f44f732 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:522b55a2-313c-45e8-b1be-07746ada5b0a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ff719d9c-8d80-42db-97a5-022a75773623 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:81e1762b-e012-4c6d-96e6-9a9f27a1880a (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f99f13ab-33c0-4304-8dc5-3a75f3909377 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:92e8390b-5173-4aa1-906d-35d2c0eaaaf6 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf157a71-f80a-4fb7-b892-7102b65a8ec0 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e79ecf77-0e0a-d7ef-e053-2a95a90a5adf (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median Tmax value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:55e262d9-d9dd-43a3-bc74-35e46dd391be (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b541252-e8a7-b678-e063-6394a90a34dc (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f755f8f3-7645-433c-b502-c1f15b700299 (opens source in a new tab)
Meclizine label
Version not recorded · Effective date not recorded
Absorption: Meclizine is absorbed after oral administration with maximum plasma concentrations reaching at a median T max value of 3 hours post-dose (range: 1.5 to 6 hours) for the tablet dosage form.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=910Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.